Wilate
Dernière mise à jour :
Wilate
Quick facts
- Dosing
20-60 IU/kg dependent on bleeding situation
- Administration
Intravenous, maximum rate of 2-3mL per minute
- Storage
+2°C and +8°C until the indicated expiry date, room temperature (max. +25°C) for up to 6 months.
What are you looking for?
Indication
Indications
- 1
Treatment and prophylaxis of spontaneous and trauma-induced bleeds in all types of VWD in adult and pediatric patients where use of DDAVP treatment is ineffective or contra-indicated.
- 2
Prevention and treatment of bleeding during and after surgical procedures.
What are you looking for?
Contraindications
Contraindications
- 1
Wilate is contraindicated for patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
What are you looking for?
Dosing
Minor Hemorrhage
Mild forms of epistaxis, oral bleeds, menorrhagia
Loading dose
20–40 IU/kgMaintenance dose
20–30 IU/kg every 12–24hrsMay need to be continued for up to 3 days
Loading dose
Maintenance dose
May need to be continued for up to 3 days
Major Hemorrhage
GI bleeds, muscle bleeding, hemarthrosis, severe refractory epistaxis.
Loading dose
40–60 IU/kgMaintenance dose
20–40 IU/kg every 12–24hrsMay need to be continued for up to 5–7 days
Loading dose
Maintenance dose
May need to be continued for up to 5–7 days
Minor surgery
Dental surgery of 1 or more teeth excluding 3rd molar(s) extraction, synovectomy excluding knee joint synovectomy, dermatological removal procedures, electrocoagulation, gastroscopy, polypectomy, ERCP.
Loading dose
30–60 IU/kgMaintenance dose
20–40 IU/kg every 12–24 hours
Loading dose
Maintenance dose
Major surgery
Knee/hip replacement, inguinal hernia repair, adenoidectomy and tonsillectomy.
Loading dose
40–60 IU/kgPlasma level of VWF: RCo of ≥60 IU/dL (≥60%) and FVIII:C of ≥40 IU/dL (≥40%) should be achieved. The dosage should be adjusted according to the extent and location of the bleeding and/or the type of surgery.
Maintenance dose
20–40 IU/kg every 12–24 hoursPlasma level of VWF: RCo of ≥60 IU/dL (≥60%) and FVIII:C of ≥40 IU/dL (≥40%) should be achieved. The dosage should be adjusted according to the extent and location of the bleeding and/or the type of surgery.
Loading dose
Plasma level of VWF: RCo of ≥60 IU/dL (≥60%) and FVIII:C of ≥40 IU/dL (≥40%) should be achieved. The dosage should be adjusted according to the extent and location of the bleeding and/or the type of surgery.
Maintenance dose
Plasma level of VWF: RCo of ≥60 IU/dL (≥60%) and FVIII:C of ≥40 IU/dL (≥40%) should be achieved. The dosage should be adjusted according to the extent and location of the bleeding and/or the type of surgery.
Prophylaxis
Preventative treatment of bleeding
- Dose
20–40 IU/kg BW should be administered 2–3 times per week.
What are you looking for?
Preparation and handling
For Blood bank
- 1
The stability of the solution at room temperature has been demonstrated for up to 4 hours.
- 2
Wilate and solvent can be stored at between +2°C and +8°C until the indicated expiry date.
- 3
If stored at room temperature (max. +25°C), wilate must either be used within 6 months or discarded.
- 4
Protect from light. Do not freeze.
For Clinicians
- 1
If a patient on prophylactic treatment missed a dose, the missed dose should be taken as soon as possible, and then treatment should continue as before.
- 2
If a dose is skipped, the next dose should not be doubled
What are you looking for?
Safety
Safety measures
- 1
Risk of infectious agents with products made from human plasma.
- 2
Risk of allergic reaction.
- 3
Patients should be monitored for risk of thrombosis.
- 4
Wilate must not be mixed with other medicinal products or administered simultaneously with other intravenous preparation in the same infusion set.
- 5
Patients with VWD, especially type 3 patients, may develop neutralizing antibodies (inhibitors)to VWF.
What are you looking for?